The declaration of tuberculosis (TB) as a global emergency by the World Health Organization [1] resulted in renewed interest in the study of the biology of Mycobacterium tuberculosis, interactions between the host and M. tuberculosis, and pathogenesis of TB. During early phases of M. tuberculosis infection, macrophages play a key role in controlling the infection, by phagocytosing mycobacteria, producing cytokines that have modulatory effects on macrophages themselves and on other cells (e.g., T lymphocytes), and regulating induction of cell-mediated specific immune response [2] .
The initial macrophage response depends on its innate capacity to recognize mycobacteria and activate antimycobacterial biochemical mechanisms [3, 4] . In recent years, accumulating evidence suggests that the fate of infected macrophages may be crucial for the subsequent events that occur within the infected host [5] [6] [7] [8] . According to results of our previous studies, apoptosis of M. tuberculosis-infected murine macrophages depends on both bacterial and phagocytic factors. Although live M. tuberculosis H37Rv and purified protein derivative (PPD) are able to induce apoptosis [7, 9, 10] , killed M. tuberculosis and mannosylated lipoarabinomannan [7, 11] inhibit apoptosis, suggesting that mycobacteria have developed mechanisms to modulate the apoptotic response of the host cells. On the phagocytic-cell side, apoptosis is influenced by the balance between tumor necrosis factor (TNF)-a and interleukin (IL)-10 produced in response to mycobacterial stimuli, suggesting that apoptosis may be involved in the innate antimycobacterial mechanisms [9, 12, 13] . However, other authors, using human monocytes and macrophages, have reported that apoptosis is induced mainly by nonvir-ulent mycobacteria [14] [15] [16] [17] [18] and that even small inocula may inhibit apoptosis of infected macrophages [19] . Although apoptotic macrophages have been found in tissue granulomas and bronchoalveolar lavages from patients with TB [6, 20, 21] , the role of apoptosis in the pathogenesis of the disease is still poorly understood.
Results from our laboratory, by use of the human promonocytic U-937 cell line, have shown that exposure of nondifferentiated cells to PPD results in changes compatible with necrosis, whereas differentiated cells undergo apoptosis [22] , suggesting that human mononuclear phagocytes may exhibit both types of cell death after exposure to mycobacterial products. This observation is relevant, since apoptosis of infected phagocytes may contain the infection and prevent the inflammatory response, whereas necrosis of such cells, with disruption of cell membrane, may lead to release of intracellular bacteria and lysosomal enzymes [23, 24] , resulting in bacterial dissemination and tissue damage. Furthermore, apoptotic infected macrophages may be determinant of the induction of CD8 + T cell-dependent responses [25, 26] . Thus, the type of cell death that occurs in infected macrophages may be crucial in the outcome of the infection.
The results presented here show that monocytes obtained from tuberculin-positive (i.e., PPD-positive) healthy control subjects undergo apoptosis when exposed to PPD or infected with M. tuberculosis, whereas monocytes from patients with TB present both apoptosis and necrosis. Both types of cell death were modulated by TNF-a and IL-10 produced in response to mycobacteria. These observations suggest that apoptosis of infected macrophages may be an important antimycobacterial defense mechanism and that, during active TB, there is a dysregulation of the mechanisms involved in the death of mononuclear phagocytes, which may partly explain the tissue damage and bacterial dissemination that occur in patients with active TB.
SUBJECTS, MATERIALS, AND METHODS
Patients and control subjects. Twenty-five patients with bacteriologically proven pulmonary TB were recruited from the Tuberculosis Clinic at Hospital La María (Medellín, Colombia). Bacteriological confirmation of TB was done by sputum acidfast staining and culture. All patients were studied within 2 weeks of diagnosis. Thirty PPD-positive control subjects were selected from the medical and laboratory personnel who voluntarily agreed to participate in the study. None of the control subjects had previously received anti-TB treatment. All subjects studied signed an informed consent form previously approved by the Ethics Committee of the Centro de Investigaciones Méd-icas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. All participants were HIV negative and underwent tuberculin skin testing with 1 TU of Tubersol (PPD CT68; Connaught). Patients with TB included 19 men and 6 women whose ages ranged from 19 to 65 years. Control subjects included 20 men and 10 women whose ages ranged from 20 to 53 years.
Sample collection and cell isolation. Fifty milliliters of venous blood was obtained under aseptic conditions and defibrinated by continuous agitation with glass beads. Defibrinated blood was centrifuged, and the buffy coat was resuspended 1:3 (vol:vol) in PBS (Gibco BRL Life Technologies). Mononuclear cells (MNCs) were obtained by centrifugation on Lymphocyte Separation Media (BioWittaker). Cell viability was determined by use of trypan blue exclusion, and the cells were resuspended at cells/mL in RPMI 1640 medium (Gibco BRL) without 6 1 ϫ 10 antibiotics and were supplemented with 10% heat-inactivated fetal calf serum (FCS; BioWittaker). In selected experiments, MNCs/well were plated in 24-well flat-bottomed culture 6 2 ϫ 10 plates (Corning), in complete medium containing 0.5% FCS, for 2 h at 37ЊC. Thereafter, nonadherent cells were removed by repeatedly washing with prewarmed PBS plus 10% FCS. The number of adherent cells was determined by mechanical removal and counting the cells in a replicate well. The purity of monocytes in the adherent cell population was determined by use of flow cytometry using anti-CD14-fluorescein isothiocyanate (FITC; clone M5E2), anti-CD3-CyCh (clone 145-2C11), anti-CD19-phycoerythrin (PE; clone M312), and anti-CD-56 (clone B159; Pharmingen) gated on the respective isotype controls. Determination of cell death. To assess apoptosis and necrosis, freshly isolated MNCs and adherent cells were stimulated with 10 mg/mL PPD (Connaught) or were infected with M. tuberculosis H37Rv at a mycobacteria:macrophage ratio of 5: 1, for 0-72 h at 37ЊC in 5% CO 2 , as described elsewhere [7] . Apoptosis was determined by analysis of hypoploidy and by determination of single DNA strand breaks by use of a TUNEL assay [7] . Simultaneous detection of apoptosis and necrosis was performed by double staining with 3,3 -dihexyloxacarbocyanine iodide (DIOC 6 ), to detect the alterations in mitochondrial permeability transition (PT) that occur during apoptosis [27] , and with ethidium bromide (EB), which stains cells with damaged cell membranes, as occurs in necrosis.
Analysis of hypoploidy by flow cytometry. The number of hypoploidic cells was determined as described elsewhere [7] . In brief, PPD-stimulated and nonstimulated MNCs 5 3 ϫ 10 from PPD-positive control subjects were fixed with 70% ethanol and resuspended in 1.5 mL of 50 mg/mL propidium iodide (PI) and 100 U/mL RNase A (Sigma Chemical). The cells were incubated for 30 min at room temperature in the dark before flow cytometric analysis. The PI fluorescence of 10 5 nuclei was determined within the monocyte gate on the basis of the forward-scatter/side-scatter dot plot. The percentage of nuclei with DNA content smaller than the normal diploid complement (higher peak in histograms) was considered to be hypoploidic.
TUNEL assay. The MEBSTAIN apoptosis kit (Medical & Biological Laboratories) was used for the TUNEL assay. In brief, cells were washed with PBS containing 2% FCS and 0.1% NaN 3 and fixed with 4% paraformaldehyde. The cells were permeabilized with 200 mL of 0.5% Tween 20, containing 0.2% bovine serum albumin (BSA), and the terminal deoxynucleotidyl transferase reaction was performed in the presence of FITCdUTP. Cells were resuspended in 100 mL of PBS, and 5 mg/mL anti-CD14-PE (clone M5E2), anti-CD3-CyCh, or the respective isotype controls were added. Counting of TUNEL-positive cells was performed by use of flow cytometry by gating the CD14 + CD3
Ϫ region.
Differentiation of apoptotic and oncotic/necrotic monocytes. To simultaneously identify oncotic/necrotic and apoptotic monocytes, cells were incubated in 100 mL of PBS containing [28, 29] . Measurement of lactate dehydrogenase (LDH) in cell culture supernatants. Since membrane leakage observed during necrosis results in release of LDH into the culture medium [18, 30] , measurement of this enzyme was used to confirm induction of this type of cell death. Cells were cultured for 48 h, in the presence or absence of PPD, and 50 mL of the supernatant fluid was collected to determine LDH concentration by use of a commercial kit (Promega). In brief, supernatants were mixed with the substrate mix buffer for 30 min at room temperature in the dark. The reaction was stopped by the addition of 1:10 volume of 1 N HCl to each sample. Finally, absorbance was determined at 490 nm.
Detection of production of TNF-a and IL-10. Adherent cells were cultured in the presence or absence of PPD or were infected with M. tuberculosis 3 ϫ 10 and were cultured in the presence of PPD or were infected with M. tuberculosis in the presence of 2.5 mg/mL anti-TNF-a or 3.0 mg/mL anti-IL-10 for 24 h. Thereafter, the cells were split for studies of apoptosis and necrosis and for intracellular determination of TNF-a, IL-10, and TUNEL.
Statistical analysis. All experiments were performed in triplicate and independently repeated at least 3 times. Data were analyzed by analysis of variance-type III of square sum. Interactions above the second level were excluded. Correlation analysis was done by use of Pearson's product moment. P ! , calculated by the interactions between the factors, was con-.05 sidered to be statistically significant. Data are presented as the confidence interval for the mean. For all analyses, mean ‫ע‬ 95% we used Statgraphics Plus software (release 2; Statgraphics).
RESULTS
To determine whether exposure to PPD induces apoptosis in human monocytes, MNCs obtained from PPD-positive control subjects were stimulated with PPD for 0-72 h. Thereafter, the cells were stained with PI, and the percentage of hypoploidic cells within the monocyte gate was determined by use of flow cytometry. PPD induced a significant time-dependent increase in the number of hypoploidic cells, a phenomenon that was not observed in nonstimulated cultures (figure 1). Significant differences between stimulated and control cultures were observed at 48 and 72 h ( ). P ! .001 That monocytes were indeed undergoing apoptosis was verified in adherent cell cultures. Adherence resulted in 91% ‫ע‬ of CD14 + cells with !5% CD3 + cells. There were no CD19 + 5% or CD56 + cells, and 95% of the cells exhibited the same forwardand side-scatter cytometric characteristics as monocytes (data not shown). To compare the apoptotic response of adherent cells (from both PPD-positive control subjects and patients with TB) to PPD, adherent cells were stained with TUNEL (figure 2). In both groups, PPD induced a significant increase in the percentage of apoptotic cells ( ). However, this increase was higher P ! .003 in PPD-positive control subjects (69.27% ‫ע‬ 13.81%) than in patients with TB ( ), suggesting that apoptosis is 32.47% ‫ע‬ 9.96% a normal response of monocytes from PPD-positive control subjects, whereas, in patients with TB, there may be alterations in monocyte death response to mycobacterial stimuli.
Whether the diminished apoptotic response observed in patients with TB may be due to a differential death response between apoptosis and necrosis was then explored. MNCs, cultured in the presence or absence of PPD, were analyzed by use of flow cytometry for mitochondrial membrane PT, as a marker of apoptosis, and for cell membrane integrity, as a marker of necrosis [28, 29] . As shown in table 1, of the 72.9% ‫ע‬ 11.5% monocytes from PPD-positive control subjects stimulated with PPD presented apoptosis, with a negligible percentage of oncotic/necrotic monocytes. In contrast, cultures from patients with TB presented apoptotic and 26% ‫ע‬ 5% 25.6% ‫ע‬ 2.5% oncotic/necrotic monocytes ( ). P ! .001 Induction of necrosis by PPD in MNCs from patients with TB was confirmed by measuring the release of LDH into culture supernatants [30] . Nonstimulated cultures from both patients with TB and PPD-positive control subjects and PPD-stimulated cells from PPD-positive control subjects had negligible levels of LDH ( induced apoptosis is modulated by TNF-a and IL-10 [6, 9, 12, 15, 17]. Thus, we assessed whether these cytokines may also be involved in the modulation of the death of monocytes from patients with TB. For this purpose, we compared the percentage of adherent cells isolated from patients with TB and from PPDpositive control subjects producing TNF-a and IL-10 under our experimental conditions (table 1). In both groups of subjects, stimulation with PPD induced a significant increase in the percentage of cells producing these cytokines ( ). P ! .002 However, there was a differential response between PPD-positive control subjects and patients with TB. Although PPDstimulated cultures from PPD-positive control subjects had TNF-a-positive cells, cultures from patients 55.0% ‫ע‬ 2.3% with TB had TNF-a-positive cells ( ) and in patients with P р .001 TB (Pearson's correlation coefficient, 0.67;
) and cor-P р .01 related negatively with necrosis in patients with TB (Spearman's rank correlation coefficient, Ϫ0.86;
). P р .001 Monocyte cultures had a small degree of contamination (∼5%) with CD3 + T lymphocytes that may also produce cytokines able to modulate macrophage cell death. Therefore, cells from PPD-positive control subjects, cultured in the presence or absence of PPD, were tested for intracellular TNF-a and IL-10 within the CD3 + and CD14 + gates (figure 3). It was not possible to detect cells producing either cytokine in nonstimulated cultures (data not shown). In PPD-stimulated cultures, there were 67% CD14 + , IL-10-positive cells were detected, whereas there were 75% CD14 + , IL-10-positive cells. These results suggest that, in adherent cell cultures stimulated with PPD, production of TNFa and IL-10 is attributable mainly to monocytes.
Finally, we further assessed the roles of TNF-a and IL-10 in PPD-induced monocyte apoptosis and necrosis by use of blockade experiments with monoclonal antibodies specific for these cytokines. Apoptosis (figure 4A) was observed in 70% ‫ע‬ 5% and of monocytes from PPD-positive control sub-45% ‫ע‬ 3% jects and patients with TB, respectively, stimulated with PPD in the presence of an irrelevant isotypic antibody ( ). P ! .002 Blockade of TNF-a by anti-TNF-a antibodies completely inhibited apoptosis ( and in monocytes from 2% ‫ע‬ 5% 5% ‫ע‬ 5% PPD-positive control subjects and patients with TB, respectively;
). In contrast, treatment with anti-IL-10 resulted P ! .002 in a significant increase of apoptotic monocytes in both PPDpositive control subjects ( ) and patients with TB 80% ‫ע‬ 5% ( ) ( ). With regard to necrosis (figure 4B), 65% ‫ע‬ 5% P ! .01 stimulation with PPD in the presence of an isotypic control antibody showed and ( ) ne-3% ‫ע‬ 1.5% 30% ‫ע‬ 2.0% P ! .001 crotic monocytes from PPD-positive control subjects and from patients with TB, respectively. Blockade of TNF-a increased the number of necrotic monocytes to in cultures from 30% ‫ע‬ 5% PPD-positive control subjects and in cultures from 42% ‫ע‬ 5% patients with TB ( ). Blockade of IL-10 did not signif-P ! .001 icantly change the percentage of necrotic monocytes in cultures from PPD-positive control subjects but reduced the number of necrotic macrophages (from 32% to ; ) 17% ‫ע‬ 5% P ! .003 in cultures from patients with TB, compared with the isotype control. Together, these results suggest that differential production of TNF-a and IL-10 may modulate necrosis and apoptosis in monocytes from patients with TB and from PPDpositive control subjects.
DISCUSSION
The results presented here clearly demonstrate that monocytes from patients with TB undergo apoptosis, as well as necrosis, after infection with virulent M. tuberculosis or exposure to PPD, whereas monocytes from PPD-positive control subjects undergo only apoptosis. Apoptosis was consistently demonstrated by quantification of hypoploidia, TUNEL, and disruption of mitochondrial PT, whereas necrosis was demonstrated by cell membrane damage and release of LDH into culture media. Previous reports from our laboratory, as well as from other laboratories, using murine and human macrophages have shown that infection with M. tuberculosis leads to apoptosis of infected cells [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . There is also evidence that soluble mycobacterial products are able to modulate apoptosis. PPD induces apoptosis of murine macrophages [7, 10] , and a sonicate from Mycobacterium avium [31] , as well as the 19-kDa lipoprotein of M. tuberculosis [32] [33] [34] , have been reported to induce apoptosis of human monocytes. In addition, there are reports indicating that apoptotic macrophages may be found in bronchoalveolar lavages and pulmonary granulomas from patients with TB [6, 20, 21] , but little is known about the significance and the mechanisms of macrophage cell death in patients with active TB. Classic descriptions of the histology of tuberculous granuloma were performed before a clear distinction between necrosis and apoptosis, as different forms of cell death, was established. Thus, those descriptions refer to caseous necrosis at the tissue level, rather than at the individual cellular level. However, it was already accepted that the "burst" of bacilliladen macrophages is involved in bacterial dissemination and tissue damage [35] . It is worth noting that one of the first descriptions of apoptosis in human monocytes infected with Mycobacterium bovis bacille Calmette-Guérin demonstrated that cells treated with ATP became apoptotic and showed a reduction in bacillary viability, but, after exposure to H 2 O 2 , monocytes underwent necrosis with no inhibition of intracellular mycobacterial replication [5] .
The demonstration that a significant percentage of monocytes from patients with TB undergo necrosis after infection with virulent M. tuberculosis or exposure to PPD may be of great importance in understanding the pathogenesis of TB. Necrosis of infected macrophages may result in the release of bacteria, lysosomal enzymes, and other proinflammatory mediators, leading to bacterial dissemination, tissue damage, and active disease. In contrast, apoptosis of infected macrophages has been considered as a defense mechanism that creates a nonpermissive environment for bacterial replication with no release of intracellular enzymes into the surrounding milieu [36, 37] . Bystander macrophages are able to kill M. tuberculosis after ingestion of apoptotic cells containing bacilli, thus avoiding spread of mycobacteria [36] . In addition, TNF-a-induced apoptosis of M. tuberculosis-infected macrophages correlated with a reduction of mycobacterial viability, whereas complementdependent cell lysis had no effect on bacterial viable counts [13] . In the Salmonella model, apoptosis, but not necrosis, of infected monocytes and macrophages limited growth of pathogens and retained bacilli within the apoptotic bodies [38] .
Protective immunity against M. tuberculosis, as expected to occur in PPD-positive control subjects, is the result of innate and acquired defense mechanisms. Recent evidence indicates that apoptotic vesicles derived from M. tuberculosis-infected macrophages are ingested by dendritic cells, resulting in crosspriming by major histocompatibility complex I-and CD1b-restricted CD8 + T cells [26] . There is a growing acceptance that activated CD8 + T cells play an important role in anti-M. tuberculosis immune response, by secretion of IFN-g and by their cytotoxic activity over infected macrophages [39] . Thus, apoptosis of infected macrophages may directly enhance protective immunity by limiting intracellular mycobacterial replication and, indirectly, by facilitating a strong CD8 + T cell response, as described elsewhere for PPD-positive individuals [40] [41] [42] [43] . Thus, apoptosis of infected phagocytes may be regarded as a direct correlate of the protective immune response that occurs in ∼90% of the infected individuals who never develop active TB during their lifetime.
Regulation of the mechanisms of phagocyte death by infection with M. tuberculosis is more complex than expected. Other authors have observed that apoptosis of human monocytes is preferentially induced by nonvirulent M. tuberculosis [14] [15] [16] [17] [18] and that, at low inoculum doses, M. tuberculosis suppress apoptosis [19] . Infected macrophages also showed a reduced susceptibility to FasL-induced apoptosis, correlating with a reduced level of Fas expression [13] . In addition, we have re-ported that structural components from the mycobacterial cell wall or heat-inactivated bacteria inhibited cell death, indicating that the metabolic activity of M. tuberculosis is required to induce cell death. It is possible that, for induction of apoptosis, in addition to host factors (such as the TNF-a:IL-10 ratio), a balance between different mycobacterial metabolic products and structural components is required to modulate host cell death and survival. Thus, at low infecting doses, antiapoptotic structural components may be more relevant, whereas, at higher doses, the threshold for the activity of proapoptotic metabolic compounds is attained more readily.
Previous studies from our laboratory have shown that induction of apoptosis in murine macrophages depends on the TNF-a:IL-10 balance [9] . In the experiments described above, the role of TNF-a and IL-10 was further confirmed and extended to the human disease. First, monocytes from PPD-positive control subjects preferentially produced TNF-a, whereas cells from patients with TB produced more IL-10 than TNFa, resulting in a higher TNF-a:IL-10 ratio in patients with TB that correlates with induction of apoptosis. Second, anti-TNFa almost completely inhibited apoptosis, whereas it increased necrosis in both PPD-positive control subjects and patients with TB. In contrast, anti-IL-10 did not have such a dramatic effect but significantly increased apoptosis in patients with TB. Although TNF-a and IL-10 may be produced by different types of cells, such as T lymphocytes and NK cells, our results suggest that, in our system, monocytes are the main source of these cytokines. These results are in agreement with those of other authors, who showed that macrophages are the main producers of these cytokines in patients with TB [44] and leprosy [45] . Regulation of mycobacterial-exposed macrophage cell death by TNF-a and IL-10 also is consistent with the role of TNF-a in formation of granulomas and protection against mycobacterial infections [46] , as well as with the deactivating and suppressive role of IL-10 [47, 48] .
With regard to induction of necrosis, it must be noted that blockade of TNF-a dramatically increased the percentage of oncotic/necrotic cells, whereas anti-IL-10 significantly decreased this percentage in patients with TB. It may be speculated that, in the absence of apoptosis, which creates a nonpermissive environment for mycobacterial growth, the bacilli continue replicating, and the host cell eventually explodes as a result of membrane damage. However, the time period studied in our experiments (48 h) is not enough to attain such a number of intracellular bacilli; thus, there must be an active mechanism in the cells of patients with TB that makes infected phagocytes more prone to this type of cell death. We hypothesize that induction of necrosis might involve an increased calcium flux, which has been observed during mycobacterial infection [11] . Calcium fluxes can activate enzymes, such as lipases or proteases [49] , other than caspases, able to digest the cytoplasmic membrane.
Elucidation of the fate of infected macrophages, the type of macrophage death that occurs during M. tuberculosis infection, and the biochemical and molecular mechanisms underlying such cell death may increase our understanding of fundamental mechanisms of protective anti-TB immune response and open new possibilities to modulate antimycobacterial and inflammatory responses in patients with active TB.
